Platelet IκB Kinase-β Deficiency Increases Mouse Arterial Neointima Formation via Delayed Glycoprotein Ibα Shedding

Authors:

Abstract
Objective—: On the luminal surface of injured arteries, platelet activation and leukocyte–platelet interactions are critical for the initiation and progression of arterial restenosis. The transcription factor nuclear factor-κB is a critical molecule in platelet activation. Here, we investigated the role of the platelet nuclear factor-κB pathway in forming arterial neointima after arterial injury. Methods and Results—: We performed carotid artery wire injuries in low-density lipoprotein receptor-deficient (LDLR –/– ) mice with a platelet-specific deletion of IκB kinase-β (IKKβ) (IKKβ fl/fl /PF4 cre /LDLR –/– ) and in control mice (IKKβ fl/fl /LDLR –/– ). The size of the arterial neointima was 61% larger in the IKKβ fl/fl /PF4 cre /LDLR –/– mice compared with the littermate control IKKβ fl/fl /LDLR –/– mice. Compared with the control mice, the IKKβ fl/fl /PF4 cre /LDLR –/– mice exhibited more leukocyte adhesion at the injured area. The extent of glycoprotein Ibα shedding after platelet activation was compromised in the IKKβ-deficient platelets. This effect was associated with a low level of the active form of A Disintegrin And Metalloproteinase 17, the key enzyme involved in mediating glycoprotein Ibα shedding in activated IKKβ-deficient platelets. Conclusion—: Platelet IKKβ deficiency increases the formation of injury-induced arterial neointima formation. Thus, nuclear factor-κB–related inhibitors should be carefully evaluated for use in patients after an arterial intervention.

This publication has 57 references indexed in Scilit: